Celebrity Inventors
Comic actor Danny Kaye received patent D166,807 for the co-design of "Blowout Toy or the Like". It's similar to one of those toys that unravels when you blow into at a birthday party except Kaye's has three blowouts going in different directions, not just one.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7326447 | Benzochromene derivatives The present invention relates to benzochromene derivatives of the formula I in which the various parameters are as defined in the text, and to liquid-crystal media which comprise these compounds, and to the use o... | 02/05/2008 |
| 7285672 | Process for isolating of α-mangostin The invention relates to a process for obtaining and purifying pure α-mangostin from the rind of the fruit (mangosteen) of Garcinia mangostana. ... | 10/23/2007 |
| 7261912 | Method of producing useful products from seawater and similar microflora containing brines A process is provided for the recovery of useful products, including fertilizers and nutritional supplements, from the organic matter and minerals contained in seawater and other brines. The dissolved organic carbon-based chemicals and suspended particulate carbon-b... | 08/28/2007 |
| 7083813 | Methods for the treatment of peripheral neural and vascular ailments Compositions and methods for the treatment of peripheral neural and vascular ailments are disclosed. The method comprises administering a flavonoid compound with antioxidant properties, optionally formulated in a acceptable carrier. This compound or combination of c... | 08/01/2006 |
| 7019024 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof. ... | 03/28/2006 |
| 6740756 | Fluorescent lanthanide chelates The present invention provides complexing agents of Formula I which contain novel photosensitizers and produce long-lived fluorescence for use in bioaffinity assays, especially HTRF (homogeneous time-resolved fluorescenc... | 05/25/2004 |
| 6458974 | Synthesis of ଲ-lapachone and its intermediates A novel process for synthesizing ଲ-lapachone (beta-lapachone), an agent that has demonstrated significant antineoplastic activity against human cancer lines. The process comprises the conversion of starting material, 2-hydroxy-1,4-naphothoquinone in... | 10/01/2002 |
| 6384045 | Tricyclic and tetracyclic pyrones This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone ring. The tricyclic oxypyrone synthetic method is a simple con... | 05/07/2002 |
| 6204396 | Method for producing calcium fulvate from humus material A method produces calcium fulvate from naturally-occurring humus material, such as leonardite, or humic shales. The humus material containing solid fulvic acid and solid humic acid is mixed with water and sodium hydroxide for a first selected period of ti... | 03/20/2001 |
| 6147229 | Method for producing magnesium fulvate from humus material A method produces magnesium fulvate from naturally-occurring humus material, such as leonardite, or humic shales. The humus material containing solid fulvic acid and solid humic acid is mixed with water and sodium hydroxide for a first selected period of ... | 11/14/2000 |
| 5977077 | Xanthone analogs for the treatment of infectious diseases Therapeutic compositions for the treatment of infectious diseases are disclosed. These compositions comprise xanthones and xanthone derivatives, such as 2,3,4,5,6-pentahydroxyxanthone. Also disclosed are methods for the treatment of infectious diseases us... | 11/02/1999 |
| 5958970 | Tricyclic and tetracyclic pyrones This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone ring. The tricyclic oxyprone synthetic method is a simple cond... | 09/28/1999 |
| 5763625 | Synthesis and use of ଲ-lapachone analogs 3-Substituted-ଲ-lapachone analogs and their use either alone or to augment chemotherapy or radiotherapy to induce programmed neoplastic cell death without exhibiting toxicity to surrounding normal cells are disclosed. In particular, 3-allyl-ଲ-... | 06/09/1998 |
| 5726208 | Heterocyclic tertiary amines New compounds of formula: ##STR1## wherein: --A--D--E, X, n, Y and Z are as defined in the description, in racemic form and in the form of optical isomers, and their addition salts with pharmaceutically acceptable acids. Those compounds may be used as med... | 03/10/1998 |
| 5672621 | Carbonarin antiinsectan metabolites Carbonarins A, B, C, D, E, F, G, and H have been isolated from the sclerotia of the fungus Aspergillus carbonarius. The carbonarius are effective for controlling Coleopteran and Lepidopteran insects. The carbonarins have the structure: ##STR1## ... | 09/30/1997 |
| 5633357 | Synthesis of carboxylic acid glucuronides A method of producing a carboxylic acid glucuronide by reacting a carboxylic acid precursor with a blocked sugar epoxide precursor is disclosed. Also disclosed are: deuterated 11-nor-Ɗ8 - or Ɗ9 -THC carboxylic acid glucuronide havi... | 05/27/1997 |
| 5623080 | Fluorone and pyronin Y derivatives A compound of the formula (I) or (II): ##STR1## where R1, R2, R5 and R6 are the same or different and represent a hydrogen atom or a halogen atom and R1 and R2 may combine to form a ri... | 04/22/1997 |
| 5597943 | Phospholipase A2 inhibitor The present invention relates to the new thielocin derivatives, which exhibit phospholipase A2 inhibitory activity of the formula: ##STR1## wherein R1, R2, R3, R4, R5, R6, R... | 01/28/1997 |
| 5563278 | Angiotensin II antagonists This invention provides novel phenyl and heterocyclic derivatives, their pharmaceutical formulations and their use for antagonizing angiotensin II receptors in mammals.... | 10/08/1996 |
| 5011952 | Phospholipase A2 inhibitor A compound of the formula: ##STR1## wherein the wave line means -bond or ଲ-bond, which compound is useful as a phospholipase A2 inhibitor. Process for the production of the compound, pharmaceutical composition containing the c... | 04/30/1991 |
| 4996230 | Leukotriene antagonists This invention provides tricyclic derivatives which are leukotriene B4 antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes... | 02/26/1991 |
| 4927849 | Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them The xanthosulfonamido and benzensulfonamido derivatives corresponding to the formula: ##STR1## wherein x represents hydrogen, alkyl, alkoxy or halogen, Y represents an alkyl, alkoxy or halogen and Z represents the group ##STR2## or Y and Z ... | 05/22/1990 |
| 4691059 | Copolymerizable UV stabilizers This invention describes UV-stabilized step growth polymers such as polyesters, polyurethanes, polycarbonates, and combinations thereof. The UV-stabilizing moieties present in these polymers comprise chemically bound, pendant ortho-hydroxydiphenyl ketone ... | 09/01/1987 |
| 4628087 | Process for the preparation of pharmacologically active compounds containing a sulfoxide group Process for the preparation of pharmacologically active compounds containing a sulfoxide group by oxidation of a thioether with hypochlorite in an alkaline medium at a pH higher than 10 and at a temperature comprised between 0° and 40° C.... | 12/09/1986 |
| 4585876 | Novel xanthones and thioxanthones Novel xanthones and thioxanthones of the formula I ##STR1## in which A, X, Y, Z, E and E' are as defined in patent claim 1, are described. A is preferably --S-- and E and E' are preferably bonded in the ortho-position relative to one another. The com... | 04/29/1986 |
| 4556651 | Secalonic acid derivatives as antitumor agents A secalonic acid derivative of the formula (I); ##STR1## wherein R is ##STR2## wherein R1 and R2 each independently is a hydrogen atom or a C1-4 alkyl group; R3 is a hydrogen atom, a C1-4 al... | 12/03/1985 |
| 4496447 | Aromatic-aliphatic ketones useful as photoinitiators Compounds of the formula ##STR1## wherein A, X, Z, R1, R2, R3, R4, n and m are defined hereinbelow are effective photoinitiators especially for the photopolymerization of ethylenically unsaturated compounds... | 01/29/1985 |
| 4424373 | Secalonic acids Secalonic acids having a 2,4'-linkage of the formula (I) or a 4,4'-linkage of the formula (II). ##STR1## .... | 01/03/1984 |
| 4290954 | Tetrahydroxanthone derivatives A tetrahydroxanthone derivative represented by the general formula: ##STR1## wherein R is a hydrogen atom, a hydroxyl, cyano, lower alkyl, lower alkoxy, lower acyloxy, benzoyloxy or tetrazolyl group, or ##STR2## (R3 is a hydrogen atom... | 09/22/1981 |
| 4250097 | Compositions for and a method of preventing diabetic complications Compositions containing and methods of employing as the essential ingredients substituted xanthone carboxylic acid compounds which are useful in the prevention of complications of diabetes. Methods for preparing these compounds and the compositions and in... | 02/10/1981 |
| 4242267 | Process for preparing 5-alkyl-7-(S-alkyl-sulfonimidoyl)-xanthone-2-carboxylic acids A novel process for the preparation of xanthane-2-carboxylic acids of the formula ##STR1## wherein R is selected from the group consisting of hydrogen and alkyl of 1 to 9 carbon atoms and R1 is alkyl of 1 to 5 carbon atoms which posse... | 12/30/1980 |
| 4221800 | Cycloalkenochromone Certain substituted cycloalkenochromones and pharmacologically acceptable salts thereof are disclosed as being useful in the treatment of allergies. The compounds have the structure: ##STR1## X is --O--, --S--, or --SO2. Y is from 1 to 4. ... | 09/09/1980 |
| 4217361 | Disubstituted xanthone-2-carboxylic acid antiallergy agents Compositions containing and methods employing, as the essential ingredient, novel substituted xanthone-2-carboxylic acid compounds which are useful in the treatment of allergic conditions. Methods for preparing these compounds and compositions and interme... | 08/12/1980 |
| 4127573 | Ditetrazole substituted acridone compounds Acridone and xanthone compounds substituted by at least one tetrazolyl group in one ring, and further substituted in the other ring, optionally for the acridones have antiallergic activity.... | 11/28/1978 |
| 4078078 | Novel xanthone-2-carboxylic acid compounds Novel xanthone-2-carboxylic acid compounds of the formula ##STR1## wherein A is selected from the group consisting of --COOR', a 1H-tetrazol-5-yl and a 1H-tetrazolylcarbamoyl, R' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carb... | 03/07/1978 |
| 4061768 | Certain cyclic carbonyl compounds used in the prophylaxis of allergic conditions A pharmaceutical composition and method for inhibiting the symptoms of allergic conditions such as asthma or allergic rhinitis which comprises administering a compound of the formula ##STR1## where Z2 is in the 6 position, wherein Z1 | 12/06/1977 |
| 4024276 | Xanthone-2-carboxylic acid compounds Novel xanthone-2-carboxylic acid compounds of the formula ##STR1## wherein A is selected from the group consisting of --COOR', a 1H-tetrazol-5-yl and a 1H-tetrazolylcarbamoyl, R' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carb... | 05/17/1977 |
| 4007205 | 7-Substituted-9-oxoxanthene-2-carboxaldehydes There are disclosed 7-substituted-9-oxoxanthene-2-carboxaldehydes of the formula: ##STR1## in which R is lower alkoxy or hydroxy. These compounds are indicated in the management of allergic manifestations such as, for example, bronchial asthma o... | 02/08/1977 |
| 3989721 | Disubstituted xanthone carboxylic acid compounds Compositions containing and methods employing, as the essential ingredient, novel disubstituted xanthone carboxylic acid compounds which are useful in the treatment of allergic conditions. Methods for preparing these compounds and compositions and interme... | 11/02/1976 |
| 3989720 | Disubstituted xanthone carboxylic acid compounds Compositions containing and methods employing, as the essential ingredient, novel disubstituted xanthone carboxylic acid compounds which are useful in the treatment of allergic conditions. Methods for preparing these compounds and compositions and interme... | 11/02/1976 |
